Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia.
about
Recently published papers: out with the old and in with the new ... then something new for the old!Alveolar hypoxia, alveolar macrophages, and systemic inflammationMonocyte chemoattractant protein-1 released from alveolar macrophages mediates the systemic inflammation of acute alveolar hypoxiaAlveolar macrophages initiate the systemic microvascular inflammatory response to alveolar hypoxiaSuppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus.Legionella pneumophila type II secretion dampens the cytokine response of infected macrophages and epitheliaInterleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZThe role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis.The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancersThe transcriptome of Legionella pneumophila-infected human monocyte-derived macrophages.Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trialCytokine Concentrations in Plasma from Children with Severe and Non-Severe Community Acquired Pneumonia.Whole Blood Transcriptome Analysis of Mycoplasma mycoides Subsp. mycoides-Infected Cattle Confirms Immunosuppression but Does Not Reflect Local InflammationThe Sphingosine-1-Phosphate Lyase (LegS2) Contributes to the Restriction of Legionella pneumophila in Murine Macrophages.Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical coursePneumonia research to reduce childhood mortality in the developing world.Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone.Associations of T helper 1, 2, 17 and regulatory T lymphocytes with mortality in severe sepsis.The role of corticosteroids in severe community-acquired pneumonia: a systematic review.Serum levels of immunoglobulins and severity of community-acquired pneumonia.Acute Inflammatory Response of Patients with Pseudomonas aeruginosa Infections: A Prospective Study.Effects of different anaesthetics on cytokine levels in children with community-acquired pneumonia undergoing flexible fibreoptic bronchoscopy.The systemic inflammation of alveolar hypoxia is initiated by alveolar macrophage-borne mediator(s)HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia.Early immune anergy towards recall antigens and mitogens in patients at onset of septic shock.Effects and safety of triamcinolone acetonide-controlled common therapy in keloid treatment: a Bayesian network meta-analysis.
P2860
Q24811894-C7E4F37C-99B4-42BE-9615-2800DAFF1991Q28389581-FA873255-910A-4961-8CD1-51B86D09BC98Q28390684-B80E3325-C04B-4E89-9CB1-3349DE909B63Q28391139-6E6DD725-F0FE-4597-8F11-4133500DD768Q30404361-A2384E98-AC52-4FF2-B156-B9C218F57137Q30429958-0E009DC6-7B13-46C3-92AF-24E29CF200E8Q34164151-E6DE478B-B5E8-42D2-AE77-C8D6C8ED8512Q34562123-6AB812C5-ABCC-4814-A734-56D467DB9387Q34903761-32DD162A-4A0B-4B5E-85DB-C037A4A6CB24Q34935542-DDB82B7A-4D52-406E-8E63-56C01FEDCE40Q35499356-15E04525-1C74-4AF9-8E4F-432F53914C75Q35559463-F9495883-4DCC-40BF-B3D3-08487C543C66Q35788577-72FA9B41-A886-4962-AFFA-8C80ABD0E15EQ35797196-6F6154C6-212B-4253-95E6-1D5A692D52E8Q35887973-6EF6A405-5813-4154-9AED-479078E4306DQ36392655-840CFEDF-73DA-489D-83E1-C571B63F1231Q36513346-250AE419-B8DF-46E4-BC50-FA2D4C2DF995Q36744785-F748DB8A-DD89-467E-9F3B-4FD351E3D3F8Q37015247-C62EE621-759C-4BA2-9158-23BB962400ECQ37189110-D6A3D059-62F6-4A93-8E0F-812E8E3CB03AQ40417136-FD1071BB-E00D-4333-9505-640F3562CA77Q40501527-780BFFC2-392C-475A-AE7B-5816F4940507Q40738561-12FC4186-94DB-4D6D-9F35-5200275D2121Q42098193-47E87120-DE82-4E43-BC40-B607F38B198BQ42499276-6D888E3F-B7F9-49D0-8AE5-56B8218D68E9Q49259114-1D57144B-B9D5-4EB2-B13A-9071E367C1E7Q55030791-D0BBC916-EAEA-4302-8FEF-1996C76EBC27
P2860
Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Molecular inflammatory respons ...... community-acquired pneumonia.
@ast
Molecular inflammatory respons ...... community-acquired pneumonia.
@en
type
label
Molecular inflammatory respons ...... community-acquired pneumonia.
@ast
Molecular inflammatory respons ...... community-acquired pneumonia.
@en
prefLabel
Molecular inflammatory respons ...... community-acquired pneumonia.
@ast
Molecular inflammatory respons ...... community-acquired pneumonia.
@en
P2093
P2860
P1476
Molecular inflammatory respons ...... community-acquired pneumonia.
@en
P2093
Francesc Gudiol
Frederic Manresa
Jordi Carratalà
Jordi Dorca
Mercè Coromines
Silvia Fernández-Serrano
P2860
P304
P356
10.1128/CDLI.10.5.813-820.2003
P577
2003-09-01T00:00:00Z